2020 Annual Research Report Tabula Rasa HealthCare: Calendar Year 2019
Copyright © 2020, Tabula Rasa HealthCare, Inc., all rights reserved. These materials are confidential and proprietary information of Tabula Rasa HealthCare, Inc. and may not be reproduced in whole or in part without the written consent of Tabula Rasa HealthCare, Inc. Table of contents
Research Strategy Committee 6
Research dissemination 10
Peer-reviewed published articles 12
Published abstracts and posters at scientific meetings 14
Published newsletters 16
Live presentations 18
Publications In press 19
Professional awards and recognition 20
Professional leadership roles 21
Peer reviewers for journals 22
Postgraduate residency programs 23
Current research projects 26 Applied Precision Pharmacotherapy Institute
SinfoníaRx corporate office
Precision Pharmacotherapy Research & Development Institute Annual report from the Tabula Rasa HealthCare, Inc. research pillar
The Tabula Rasa HealthCare (TRHC) Research & Development Pillar is committed to the development and dissemination of population health and patient-specific, data-driven technology and solutions that optimize medication regimens, manage medication risks, improve patient outcomes, reduce hospitalizations, and decrease healthcare costs.
Last year was transformational for the TRHC Research & Development Pillar, as it marked the unification of numerous nationwide research collaborators, including partners from the Precision Pharmacotherapy Research & Development Institute, Applied Precision Pharmacotherapy Institute, TRHC's Healthcare Analytics department, DoseMe, SinfoníaRx, The University of Arizona College of Pharmacy, and The Ohio State University Institute of Therapeutic Innovations and Outcomes.
In 2019, our mission to disseminate outcomes specific to TRHC solutions led to an impressive volume of publications. Our researchers published 26 papers in renowned journals, including the British Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, The Journal of the American Osteopathic Association, Epilepsy Research, Journal of the American Pharmacists Association, and Xenobiotica. Research and Development Pillar members were cited 187 times last year in the areas of pharmacogenomics, drug-drug interactions, medication therapy management, transitions of care, and cytochrome P450 activity.
Our national team gained stakeholder knowledge as they served in more than 45 leadership roles in professional organizations. Our team also contributed to the research community by actively participating as peer reviewers for more than 20 leading journals, producing 37 abstracts and poster exhibits, and leading 34 live scholarly presentations.
Congratulations to our valued members of the TRHC Research & Development Pillar who received more than 36 professional awards last year! As we look forward, we are excited to strengthen our reputation in the healthcare industry as a leading provider of high-quality research, with 9 papers already in-press with prominent journals.
Dr. Jacques Turgeon Chief Scientific Officer Tabula Rasa HealthCare
Research Strategy Committee
The TRHC Research Strategy Committee is composed of members from the Applied Precision Pharmacotherapy Institute, SinfoníaRx, Precision Pharmacotherapy Research and Development Institute, The Ohio State University Institute of Therapeutic Innovations and Outcomes, and The University of Arizona. The committee meets monthly to advocate for research dissemination and to support TRHC's mission and vision.
Page 6 Jenny Bingham, PharmD, BCACP, is President of the TRHC Research Strategy Committee. She promotes the excellence and growth of TRHC through oversight of research from project conceptualization to outcomes dissemination. Dr. Bingham is passionate about advancing the role of pharmacists in the telehealth setting and was recognized as the Next-Generation Pharmacist® Technology Innovator of the Year for her efforts in successfully leveraging telehealth pharmacy models to advance patient care standards and business profitability.
Sandra Leal, PharmD, MPH, FAPhA, CDE, is Executive Vice President of the TRHC Health Plans and Payers Business Unit. Dr. Leal is responsible for oversight and forward-thinking expansion of pharmacists’ services that focus on outcomes, access, and quality. Dr. Leal was recognized as the American Pharmacists Association Good Government Pharmacist-of-the-Year for her advocacy work on pharmacist provider status and is the president-elect of the American Pharmacists Association for the 2020-2021 term.
Veronique Michaud, PhD, BPharm, is Chief Operating Officer of the TRHC Precision Pharmacotherapy Research & Development Institute in Orlando, Florida. She is an adjunct professor, Faculty of Pharmacy, at the University of Montreal and has directed a pharmacokinetic and bioanalytic core facility at the University of Montreal Hospital Research Centre. Her research investigates the contribution of cyptochrome 450 drug- metabolizing enzymes in drug disposition, with special attention on the role of disease states, focusing on type 2 diabetes mellitus. She has earned more than $22 million in research awards, published more than 40 peer-reviewed journal articles, and mentored graduate students and PharmD residents. Dr. Michaud completed fellowships at Indiana University in Indianapolis and McGill University in Montreal and earned Doctoral and Master of Science degrees at the University of Montreal in Canada.
Page 7 Research Strategy Committee (Continued)
Milap C. Nahata, PharmD, MS, is Founding Director of the Institute of Therapeutic Innovations and Outcomes at The Ohio State University College of Pharmacy. He has published more than 600 peer-reviewed journal articles, book chapters, and five books about the clinical pharmacokinetics, pharmacodynamics, effectiveness, and safety of medications used in adult and pediatric patients. Additional research interests include impact of the population’s social determinants on their health outcomes with the usage of medications.
Luke Oglesby, BS, is a SinfoníaRx Business Systems Analyst. He received a Bachelor of Science in Biology with a minor in Health Care Management from Metropolitan State University of Denver in Colorado. Luke is responsible for ensuring that SinfoníaRx can provide the most valuable data possible for client outcome reports.
Jeniece Roher, CIPP/US, CIPP/G, MCM, is Chief Compliance Officer, HIPAA Privacy Officer at TRHC. She provides multifaceted leadership for the organizational compliance program and serves as the individual responsible for establishing and implementing an effective compliance program to prevent illegal, unethical, or improper conduct.
Vanessa Ruiz, BS, is Project Manager & Operations Coordinator at The University of Arizona College of Pharmacy Research Team. Vanessa has more than three years of experience in project and relationship management and strategic planning in research and business, including as an external affairs associate to improve policies for high- performing, low-income Arizona K-12 schools. Since joining the research team, she has been instrumental in expanding and improving day-to-day operations; elevating the team’s overall efficiency and effectiveness; and collaborating with partner organizations on the communication, design, and dissemination of innovative research.
Page 8 Nicole Scovis, PharmD, BCPS, BCACP, is Director of Strategic Growth at TRHC, where she pilots new pharmacy services in areas such as integrated behavioral health clinics, accountable care organizations, and private wellness programs. Program implementation focuses on improvement in clinical, economic, and humanistic outcomes, and ultimately on sustainability and scalability to allow broader access to these services. Dr. Scovis also helps to develop and maintain clinical programs across the SinfoníaRx line of business and serves as a faculty member at The University of Arizona College of Pharmacy.
Ann M. Taylor, MPH, MCHES, is Editor and Director of Operations for The University of Arizona College of Pharmacy Research Team and plays a key role in compliance and editorial review, as well as in ensuring rapid dissemination of research results for the research team and partnering organizations. Her extensive research career has involved coordinating Phase I-III clinical studies for refractory cancers, large-scale federal grants, and contracts with national and state entities. She has collaborated with interprofessional teams on the development and evaluation of innovative programs for diverse audiences. Ann is a Master Certified Health Education Specialist (MCHES) who has authored more than 30 peer-reviewed publications on cancer prevention, medication therapy management, and end-of-life care, and she has presented at regional and national conferences.
Jacques Turgeon, PhD, BPharm, Chief Scientific Officer of TRHC and is recognized internationally for his excellence in research and pharmacy education. He has received more than $70 million in research awards, authored more than 145 peer-reviewed articles, and mentored nearly 70 students. His research interests focus on studying factors responsible for the intersubject variability in drug response, and he is renowned for his expertise in the role of pharmacogenetics in cardiovascular drug actions. Dr. Turgeon is also professor emeritus at the University of Montreal, fellow of the Canadian Academy of Health Sciences, and fellow of the Académie Nationale de Médecine, France.
Terri Warholak, PhD, RPh, FAPhA, CPHQ, is a professor in the Department of Pharmacy Practice and Science and Assistant Dean of Academic Affairs and Assessment at The University of Arizona College of Pharmacy in Tucson. As Director of The University of Arizona College of Pharmacy Research Team, Terri oversees all research activities, mentors graduate students and postgraduate year-2 residents, and collaborates on projects with SinfoníaRx and TRHC. She serves on numerous national committees, including the U.S. Food and Drug Administration Drug Safety and Risk Management Advisory Committee and the Pharmacy Quality Alliance Research Coordinating Committee. She has published more than 110 papers and has presented at local, state, national, and international venues on topics that include medication error reduction, measure development, and quality improvement.
Page 9 Research dissemination
Note: Data were collected January 29, 2020, and include a comprehensive list of publications from SinfoníaRx, the Precision Pharmacotherapy Research & Development Institute, and the Applied Precision Pharmacotherapy Institute in renowned journals. H-index: 11
387 Citations to Date
89 Publications to Date Peer-reviewed published articles
1. Al Rihani S. The Blood-Brain Barrier as a Therapeutic 9. Bain K, Matos A, Knowlton C, McGain D. Genetic Target for Alzheimer’s Disease and Related Disorders. variants and interactions from a pharmacist- PhD dissertation, Auburn University. May 2019. led pharmacogenomics service for PACE. Pharmacogenomics. 2019;20(10):709-718. doi: 10.2217/ 2. Al Rihani S, Darakjian L, Kaddoumi A. Oleocanthal-rich pgs-2019-0047. extra-virgin olive oil restores the blood-brain barrier function through NLRP3 Inflammasome inhibition 10. Bankes D, Amin N, Bardolia C, Awadalla M, Knowlton simultaneously with autophagy induction in TgSwDI C, Bain K. Medication-related problems encountered mice. ACS Chem Neurosci. 2019;10(8):3543-3554. in the Program of All-Inclusive Care for the Elderly: doi: 10.1021/acschemneuro.9b00175. Epub 2019 Jun An observational study. J Am Pharm Assoc. 2019 25. PubMed PMID: 31244050; PubMed Central Dec 16. pii: S1544-3191(19)30494-7. doi: 10.1016/j. PMCID: PMC6703911. japh.2019.10.012. [Epub ahead of print]
3. Al Rihani S, Lan R, Kaddoumi A. Granisetron alleviates 11. Bikmetov R. Dynamic energy distribution in smart Alzheimer's disease pathology in TgSwDI mice through grids enabled by internet of things sensors and hybrid calmodulin-dependent protein kinase II/cAMP- telecom networks. The University of North Carolina at response element binding protein pathway. J Alzheimers Charlotte, ProQuest Dissertations Publishing, 2019. Dis. 2019;72(4):1097-1117. doi: 10.3233/JAD-190849. 13863214. PubMed PMID: 31683487. 12. Bingham J, Campbell P, Schussel K, Taylor A, Boesen 4. Almodóvar A, Nahata M. Associations between K, Harrington A, Leal S, Warholak T. The Discharge chronic disease, polypharmacy, and medication related Companion Program: An interprofessional collaboration problems among Medicare beneficiaries.J Manag Care in transitional care model delivery. Pharmacy (Basel). Spec Pharm. 2019;25(5):573-577. doi: 10.18553/ 2019;7(2). pii: E68. doi: 10.3390/pharmacy7020068. jmcp.2019.25.5.573. 13. Chinthammit C, Harrington A, Wild A, Werner S, 5. Almodóvar A, Nahata M. Potentially unsafe chronic Boesen K, Taylor A, Warholak T. Retrospective review of medication use among older adult chronic opioid users. exceptions for angiotensin-converting enzyme inhibitors Pharmacotherapy. 2019;39(2):140-149. doi: 10.1002/ (ACEIs) or angiotensin II receptor blockers (ARBs) phar.2218. recommendations for a diabetic Medicare population. J Manag Care Spec Pharm. 2019;25(3):358-365. doi: 6. Axon D, Taylor A, Vo D, Bingham J. Initial 10.18553/jmcp.2019.25.3.358. assessment of an interprofessional team delivered telehealth program for patients with epilepsy. 14. Clermont V, Grangeon A, Barama A, Turgeon J, Epilepsy Res. 2019;158:106235. doi: 10.1016/j. Lallier M, Malaise J, Michaud V. Activity and mRNA eplepsyres.2019.106235. expression levels of selected cytochromes P450 in various sections of the human small intestine. Br J 7. Bain K, McGain D, Cicali E, Knowlton C, Michaud V, Clin Pharmacol. 2019;85(6):1367-1377. doi: 10.1111/ Turgeon J. Precision medication: An illustrative case bcp.13908. Epub 2019 Apr 13. PubMed PMID: series guiding the clinical application of multi-drug 30817016; PubMed Central PMCID: PMC6771396. interactions and pharmacogenomics. Clin Case Rep. 2019:1-8. 15. Grangeon A, Clermont V, Barama A, Gaudette F, Turgeon J, Michaud V. Development and validation 8. Bain K, Knowlton C. Role of opioid-involved drug of an absolute protein assay for the simultaneous interactions in chronic pain management. J Am quantification of fourteen CYP450s in human Osteopath Assoc. 2019;119(12):839-847. doi:https:// microsomes by HPLC-MS/MS-based targeted doi.org/10.7556/jaoa.2019.136. proteomics. J Pharm Biomed Anal. 2019;173:96-107. doi: 10.1016/j.jpba.2019.05.006. Epub 2019 May 4. PubMed PMID: 31125949.
Page 12 16. Gravel S, Chiasson J, Gaudette F, Turgeon J, Michaud 23. Michaud V, Tran M, Pronovost B, Bouchard P, Bilodeau V. Use of 4β-hydroxycholesterol plasma concentrations S, Alain K, Vadnais B, Franco M, Bélanger F, Turgeon as an endogenous biomarker of CYP3A activity: J. Impact of GSTA1 polymorphisms on busulfan oral Clinical validation in individuals with type 2 diabetes. clearance in adult patients undergoing hematopoietic Clin Pharmacol Ther. 2019;106(4):831-840. doi: stem cell transplantation. Pharmaceutics. 2019;11(9). 10.1002/cpt.1472. Epub 2019 Jun 5. PubMed PMID: doi: 10.3390/pharmaceutics11090440. PubMed 31002385. PMID: 31480560; PubMed Central PMCID: PMC6781287. 17. Gravel S, Chiasson J, Turgeon J, Grangeon A, Michaud V. Modulation of CYP450 activities in 24. Schussel K, Forbes S, Taylor AM, Cooley J. patients with type 2 diabetes. Clin Pharmacol Ther. Implementation of an interprofessional medication 2019;106(6):1280-1289. doi: 10.1002/cpt.1496. Epub therapy management experience. Amer J Pharm Educ. 2019 Jul 9. PubMed PMID: 31099895. 2019;83(3):6584. doi: 10.5688/ajpe6584.
18. Gravel S, Panzini B, Belanger F, Turgeon J, Michaud 25. Tetuan C, Axon D, Bingham J, Boesen K, Lipsy R, V. A pilot study towards the impact of type 2 diabetes Scovis N, Taylor A, Warholak T, Lott B, Leal S. Assessing on the expression and activities of drug metabolizing the impact of pharmacists’ recommendations during a enzymes and transporters in human duodenum. Int J telehealth interprofessional epilepsy appointment and Mol Sci. 2019;20(13). doi: 10.3390/ijms20133257. their alignment with quality measures. J Manag Care PubMed PMID: 31269743; PubMed Central PMCID: Spec Pharm. 2019;25(12):1334-1339. doi: 10.18553/ PMC6651059. jmcp.2019.25.12.1334.
19. Hall-Lipsy E, Anderson E, Taylor A, Warholak T, Axon 26. Zhang Y, Wang Y, Lei Z, Zhang G, Zhang X, Wang D, D, Faqeeri Z, Jastrzab R. Community health worker Al-Rihani S, Shukla S, Ambudkar S, Kaddoumi A, Shi perspectives of an academic-community medication Z, Chen Z. Regorafenib antagonizes BCRP-mediated therapy management collaboration. J Amer Pharm multidrug resistance in colon cancer. Cancer Lett. Assoc. 2020 Jan 6. pii: S1544-3191(19)30526-6. doi: 2019;442:104-112. doi: 10.1016/j.canlet.2018.10.032. 10.1016/j.japh.2019.11.018. [Epub ahead of print] Epub 2018 Oct 28. PubMed PMID: 30392788.
20. Huguet J, Gaudette F, Michaud V, Turgeon J. Development and validation of probe drug cocktails for the characterization of CYP450- mediated metabolism by human heart microsomes. Xenobiotica. 2019;49(2):187-199. doi: 10.1080/00498254.2018.1438684. Epub 2018 Mar 8. PubMed PMID: 29448869.
21. Leal S (contributor), et al. Standards of medical care in diabetes—2020 abridged for primary care providers. Clin Diab. American Diabetes Association. December 20, 2019. Published online doi.org/10.2337/cd20- as01. https://clinical.diabetesjournals.org/content/ diaclin/early/2019/12/18/cd20-as01.full.pdf. Accessed February 3, 2020.
22. Leal S (contributor), et al. Building a successful ambulatory care practice, 2nd ed. Bethesda, MD: American Society of Health-System Pharmacists; 2019.
Page 13 Published abstracts and posters at scientific meetings
1. Abeln B, Towers T, Smith E. Commercial response to 9. Axon D, Chinthammit C, Taylor A, Pickering M, Black the opioid crisis. El Rio/The Wright Center for Graduate H, Warholak T, Campbell P. A retrospective database Medical Education Community Health Research Fair. analysis evaluating the relationship between Pharmacy May 2019 (Community Outreach Award). Quality Alliance adherence measure performance and healthcare costs and utilization for commercially 2. Abeln B, Towers V. Nursing students’ perspectives of insured patients on renin-angiotensin system (RAS) an interprofessional education program. Arizona Nurses antagonists. Supplement to J Manag Care Spec Pharm. Association Centennial Conference. September 2019. 2019;25(3a):S68. (Bronze Medal Abstract)
3. Almodóvar A, Malfara A, Nahata M. Implementation 10. Axon D, Bingham J. Evaluation of a multidisciplinary of automated targeted medication electronic alerts telehealth program for patients with epilepsy. Value in to reduce potentially inappropriate medication use Health. 2019;22(suppl 2):S282. among Medicare enrolled patients with dementia. American College of Clinical Pharmacy Annual Poster 11. Axon D, Johnson M, Abeln B, Forbes S, Anderson E, Symposium. October 2019. Manygoats T, Hall-Lipsy E. Evaluation of medication- related problems among rural community dwelling 4. Almodóvar A, Nahata M. Assessing the off-label use patients receiving medication therapy management of medications among patients with type 1 diabetes in for diabetes and/or hypertension. Value in Health. the T1D diabetes exchange: An exploratory analysis. 2019;22(suppl 2):S262. American Society of Health-Systems Pharmacists. Midyear Annual Meeting. December 2019. 12. Axon D, Vaffis S, Campbell P, Black H, Pickering M, Warholak T, Chinthammit C. A retrospective database 5. Almodóvar A, Nahata M. Effectiveness of insulin analysis assessing the relationship between Pharmacy plus off label use of sodium-glucose cotransporter-1 Quality Alliance defined cholesterol medication inhibitors versus insulin alone in type-1 diabetes: A real- adherence and disease state control, healthcare world observational analysis. International Society of utilization and costs in a Medicare supplemental sample. Pharmacoeconomic Outcomes Research Conference. Value in Health. 2019;22(suppl 2):S138. May 2019. 13. Bikmetov R. Autonomous charging stations: Genesis 6. Almodóvar A, Nahata M. Potentially harmful of machine to machine services industry within human medication use among Medicare enrolled patients with independent ecosystem. Center for Advanced Power heart failure. American College of Clinical Pharmacy Engineering Research Spring Meeting. March 2019. Annual Poster Symposium. October 2019. 14. Bingham J, Benson C, Lee H, Michael R. Investigating 7. Almodóvar A, Smith K, Nahata M. Relationship the effects of mental health medication adherence between patient characteristics and administrative on PDC rates. The University of Arizona College of burden to complete a telephonic comprehensive Pharmacy Poster Session. May 2019. medication review. American College of Clinical Pharmacy Annual Poster Symposium. October 2019. 15. Cahill S, Dabney C, Ocano D, Lipsy R, DiLeo J, Kloster J. Respiratory alert exception analysis. The University 8. Atikelet H, Beck M, Pyle M, Calabro K. Evaluating cost of Arizona College of Pharmacy Poster Session. April deficit incurred by pharmacy technician medication 2019. reconciliation for Comprehensive Medication Reviews (CMR) lost to pharmacist follow-up. The University of Arizona College of Pharmacy Poster Session. April 2019.
Page 14 Published abstracts and posters at scientific meetings
16. Campbell P, Axon D, Mollon L, Taylor A, Pickering M, 23. DiLeo J, Everett W, Morales K, Rojas H, Tacadena Black H, Warholak T, Chinthammit C. A retrospective H, Zingale D. Assessment of medication knowledge database analysis evaluating the relationship between in medication therapy management employees. Pharmacy Quality Alliance adherence measure Assessment of employees’ medication knowledge performance and healthcare costs and utilization in medication therapy management (MTM). ASHP for commercially insured patients on diabetes Midyear Annual Meeting. December 2019. medications. Supplement to J Manag Care Spec Pharm. 2019;25(3a):S38-39. 24. Gravel S, Gaudette F, Chiasson J, Turgeon J, Michaud V. Use of 4β-hydroxycholesterol plasma concentration 17. Campbell P, Axon D, Taylor A, Pickering M, Black as an endogenous biomarker of CYP3A activity: Clinical H, Bhattacharjee S, Warholak T, Chinhammit C. validation in patients with type 2 diabetes. American Relationship between adherence to anti-diabetic, Society for Pharmacology and Therapeutics Meeting, anti-hypertensive, and lipid lowering medications and Washington, DC, March 2019. healthcare utilization and expenditure in a Medicare supplemental sample. Res Social Admin Pharm. 25. Guerra B, Vaffis S, Axon D, Leal S, Scovis N. 2019.15:e29-e30. (Gold Medal Abstract) Community health workers’ and pharmacists’ perceptions and experiences of an academic- 18. Campbell P, Axon D, Taylor A, Pickering M, Black community partnership providing telephonic medication H, Bhattacharjee S, Warholak T, Chinhammit C. therapy management services: A focus group study. Relationship between adherence to anti-diabetic, American Society of Health-System Pharmacists. June anti-hypertensive, and lipid lowering medications and 2019. healthcare utilization and expenditure in a Medicare supplemental sample. Pharmacy Quality Alliance 26. Jamjoom O, Marupuru S, Warholak T, Bingham J, Annual Meeting. May 2019. Scovis N. Provider acceptance of transition of care pharmacist-led interventions based on communication 19. Carbonneau W, Kazemnia I, Patel N, Bingham J. method. American Society of Health-System Community pharmacy based adherence interventions Pharmacists. June 2019. aimed to improve diabetes medication adherence. The University of Arizona College of Pharmacy Poster 27. Le L, Paulk I, Pham T, Boesen K, Bingham J. Variance Session. April 2019. in state legislation allowing pharmacists to legally convert prescriptions from a 30- to 90-day supply for 20. Chinthammit C, Axon D, Anderson S, Taylor A, chronic medications. Comparison of 90 day conversion Pickering M, Black H, Warholak T, Campbell P. regulations based on geographic state. The University A retrospective database analysis evaluating the of Arizona College of Pharmacy Poster Session. April relationship between Pharmacy Quality Alliance 2019. cholesterol medication adherence measure performance and economic outcomes for commercially insured 28. Lipsy R, et al. Assessment of tools that test for internal patients. Supplement to J Manag Care Spec Pharm. validity. The University of Arizona College of Pharmacy 2019;25(3a):S70. Poster Session. May 2019.
21. Dhatt H, Marupuru S, Campbell P, Chinthammit 29. Marupuru S, Axon D, Chinthammit C, Campbell C, Warholak T. A motivational factors assessment P, Forbes S, Warholak T. Exploring awareness of instrument for employees providing Medication Therapy performance criteria and motivating factors of Management services: A Rasch analysis. Supplement to clinical employees at an academic based medication J Manag Care Spec Pharm. 2019;25(3a):S90. management center: Findings from focus groups. Supplement to J Manag Care Spec Pharm. 22. DiLeo J, Everett W, Morales K, Rojas H, Tacadena 2019;25(3a):S12. H, Zingale D. Assessment of medication knowledge in medication therapy management employees. The University of Arizona College of Pharmacy Poster Session. April 2019.
Page 15 Published abstracts and posters at scientific meetings
30. Marzella F, Lowe R, Welton M, Bingham J, Boesen K. 34. Sabourenkov P, M Bioniof (Adv), McLeay R. AUC24 Measuring adherence trends among patients taking a vancomycin Bayesian-based dosing: Increasing 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG- therapeutic target attainment with decreased TDM CoA) reductase inhibitor. El Rio/The Wright Center cost. Presented at the IDWeek™ 2019 Meeting. for Graduate Medical Education Community Health Washington, DC. October 2019. Research Fair. May 2019. 35. Sabourenkov P, M Bioniof (Adv), McLeay R. Predictive 31. Marzella F, Lowe R, Welton M, Bingham J, Boesen K. ability and bias of vancomycin population PK models in Measuring adherence trends among patients taking a an obese adult population. Presented at the IDWeek™ 3-hydroxy-3-methylglutaryl-coenzyme-A (HMG- 2019 Meeting. Washington, DC. October 2019. CoA) reductase inhibitor. The University of Arizona College of Pharmacy Poster Session. May 2019. 36. Tran M, Pronovost B, Bouchard P, Bilodeau S, Alain K, Vadnais B, Franco M, Turgeon J, Michaud 32. Moczygemba L, Johnsrud M, Barner J, Bingham V. Influence of GSTA1 polymorphisms on the oral J. A descriptive analysis of 2016 Medicare Part D clearance of busulfan using limited sampling methods Medication Therapy Management Comprehensive in adult patients undergoing hematopoietic stem cell Medication Review completion rates. Presented, in transplantation. American Society for Pharmacology part, at the Academy of Managed Care and Specialty and Therapeutics Meeting. Washington DC. March Pharmacy Nexus Meeting. J Man Care Spec Pharm. 2019. (Special Poster Session: Pharmacogenomics and October 2019;24(suppl 10a): S1-S112. for the Presidential Trainee Award)
33. Orsini R, Trinh H, Forbes S. Identifying barriers 37. Vaffis S, Axon D, Chinthammit C, Black H, Pickering to adherence amongst patients speaking different M, Warholak T, Campbell PJ. A retrospective database languages. The University of Arizona College of analysis assessing the relationship between Pharmacy Pharmacy Poster Session. May 2019. Quality Alliance defined anti-diabetic medication adherence and disease state control, healthcare utilization and costs in a Medicare supplemental sample. Value in Health. 2019;22(suppl 2):S161.
Published newsletters
1. Ballinghoff T. Clopidogrel use in individuals with 3. Bardolia C. Don't be left high and dry: Consider altered CYP2C19 enzyme function: Implications of a OTC ophthalmic lubricants before other expensive pharmacogenomics case. PACE Newsletter. 2019. alternatives. The Clinical Inquirer. 2019.
2. Ballinghoff T. New drug update: Spravato™ 4. Skalski B. New drug update: Baloxavir marboxil (esketamine). The Clinical Inquirer. 2019. (XofluzaTM).The Clinical Inquirer. 2019.
Page 16 Published abstracts and posters at scientific meetings Live presentations
1. Bain K. Drug Interactions Involving antipsychotics in 9. Bingham J (faculty). The role of the telehealth PACE. Trinity Health Program of All-inclusive Care for pharmacist ACPE accredited webinar. American the Elderly (PACE) Educational WebEx Series. April Pharmacists Association. January 2019. 2019. 10. Coleman A. Telephonic Medication Therapy 2. Ballinghoff T. Chronic obstructive pulmonary disease Management. Ferris State University College of update 2019. Tabula Rasa HealthCare University. April Pharmacy Lecture. April 2019. 2019. 11. Deodhar M, Simeone KA, Simeone TA. PPARg 3. Ballinghoff T. Impact of a pharmacist-driven opioid Phosphorylation: A novel target in epilepsy. 3-minute safety initiative on drug-drug interactions in the thesis competition. Creighton University, Omaha. program of all-inclusive care for the elderly (PACE) 2019. setting: A pilot study. Eastern States 38th Annual Conference. April 2019. 12. DiLeo J. Geriatric pearls. Arizona Geriatric’s Society. November 2019. 4. Bardolia C. Herbal supplementation in the elderly. Tabula Rasa HealthCare University. May 2019. 13. Fankhauser M. Neuropharmacology and pharmacodynamics. The University of Arizona. 5. Bardolia C. Impact of pharmacist-driven medication November 2019. safety reviews and polypharmacy calls in the program of all-inclusive care for the elderly (PACE) setting. 14. Fankhauser M. Substance-related use and mental health Eastern States 38th Annual Conference. April 2019. disorders: Update on national trends in healthcare. The University of Arizona. November 2019. 6. Bardolia C. Developing perspectives on pharmacogenomics: Definitions and casic concepts. 15. Fankhauser M. Pharmacy Quality Alliance psychiatric Tabula Rasa HealthCare University. March 2019. certification. Arizona Pharmacy Association. October 2019. 7. Bikmetov R. Secure, resilient, and safety critical architecture of charging stations for unsupervised 16. Fankhauser M. Pharmacy Quality Alliance pain autonomous vehicles. University of North Carolina at management certification course. Arizona Pharmacy Charlotte Graduate Research Symposium. (3rd place Association Webinar. July 2019. award) 17. Fankhauser M. Pain management certificate program. Published newsletters 8. Bingham J. Next generation member engagement Arizona Pharmacy Association. March 2019. strategies to improve medication adherence. American Case Management Association Webinar. May 2019.
Page 17 Live presentations
18. Fankhauser M. Preventative health approaches: 25. Leal S. Tools and strategies to rise to the top of your Nutrition, exercise, sleep, and hormone balance. The pharmacy career. The University of Iowa College of University of Arizona College of Pharmacy. February Pharmacy. November 2019. 2019. 26. Lipsy R. 2019 New drugs update. Arizona Pharmacy 19. Fomeche F, Root K, Aminazong W, Black M. User Association Annual Meeting. June 2019. acceptance of newly formatted call scripts. The University of Arizona College of Pharmacy Poster 27. Matlock D. Medication Therapy Management career Session. April 2019. opportunities for future pharmacists. Washington State University Lunch and Learn Career Seminar. November 20. Forbes S. Implementing the pharmacists’ patient care 2019. process: Lessons learned from nursing education. The University of Arizona College of Pharmacy & 28. Matos A. Incorporation of PGY-1 pharmacy residents Midwestern University Preceptor Development into a pharmacogenomics (PGx) service for the Webinar. January 2019. Program of All-inclusive Care for the Elderly (PACE). American Society of Health-System Pharmacists 21. Guerra B. Community health workers’ and pharmacists’ National Pharmacy Preceptor Conference. October perceptions and experiences of an academic- 2019. community partnership providing telephonic medication therapy management services: A focus group study. 29. Morales K, Forbes S, Calabro K. Journey in pharmacy. Southwestern States Residency Conference. June The University of Arizona College of Pharmacy. 2019. October 2019.
22. Guerra B. Community health workers’ and pharmacists’ 30. Skalski B. Implementation of a pharmacist-driven perceptions and experiences of an academic- antipsychotic deprescribing initiative in the Program of community partnership providing telephonic medication All-inclusive Care for the Elderly (PACE) Setting: A therapy management services: A focus group study. pilot study. Eastern States 38th Annual Conference. American Society of Health-System Pharmacists. June April 2019. 2019. 31. Skalski B. Drug-specific deprescribing in the geriatric 23. Jamjoom O. Provider acceptance of transition of care population. Tabula Rasa HealthCare University. March pharmacist-led interventions based on communication 2019. method. Southwestern States Residency Conference. June 2019. 32. Stanislaw J, De Santiago A. Welcome MAT: Managing opioid use disorder. Arizona Pharmacy Association Fall 24. Jamjoom O. Provider acceptance of transition of care Conference. September 2019. pharmacist-led interventions based on communication method. American Society of Health-System 33. Turgeon J, Badea G, Bikmetov R, Cicali B, Hodges Pharmacists. June 2019. A, Jin H, Michaud V, Stein A, Verzicco J. Historical review of TRHC MedWise Risk Score: Development and current visual in various populations. Tabula Rasa HealthCare. June 2019.
34. Turgeon J, Michaud V. Drug-induced and disease- induced phenoconversion. Genotype to Multiple Phenotypes Webinar. April 2019.
Page 18 Live presentations Publications in press
1. Almodóvar AS, Nahata M. Potentially harmful 8. Turgeon J, Michaud V. Medication monitor: Decreasing medication use among Medicare patients with heart adverse drug events. Accepted for publication by Today’s failure. Accepted for publication by Am J Cardiovasc Geriatric Medicine. Drugs.
2. Anderson E, Axon DR, Taylor AM, Towers V, Warholak T, Johnson M, Forbes S, Manygoats T. Impact of a four-year academic-community partnership in provision of medication management and tertiary prevention services for rural patients with diabetes and/ or hypertension. Prev Med Rep. 2019 Dec 31;17:101038. doi: 10.1016/j.pmedr.2019.101038. eCollection 2020 Mar.
3. Bingham J, Almodóvar AS, Lee H, Benson C, Michael R, Azurin C-M, Taylor AM. The role of the pharmacist in mental health: An investigation of the impact of a pharmacist led interventions on psychotropic medication adherence in patients with diabetes. Accepted for publication by J Amer Pharm Assoc.
4. Galiano L, Hinge N, Kurlin K, Michaud V, Turgeon J. Basic mechanisms and clinical relevance of drug- induced long QT syndrome: Block of hERG, drug metabolism and drug transport in the heart. Accepted for publication by Ann Pharmacol Pharm.
5. Hall-Lipsy E, Anderson EJ, Taylor AM, Warholak T, Axon DR, Faqeeri Z, Jastrzab R. Community health worker perspectives of an academic-community Medication Therapy Management collaboration. Authors. Title. J Am Pharm Assoc. 2020 Feb 6. pii: S1544- 3191(20)30004-2. doi: 10.1016/j.japh.2019.12.022. [Epub ahead of print]
6. Jamjoom O, Marupuru S, Taylor AM, Warholak T, Bingham J, Scovis N. Evaluating provider acceptance of pharmacist interventions in the Discharge Companion Program and its impact on readmission reduction. Accepted for publication J Amer Pharm Assoc.
7. Sid-Otmane L, Hamadjida A, Nuara S, Bedard D, Gaudette F, Gourdon J, Michaud V, Beaudry F, Panisset M, Huot P. Selective metabropic glutamate receptor 2 positive allosteric modulation alleviates psychosis-like behaviors and dyskinesia in the MPTP- lesioned marmoset. Eur J Pharmacol. 2020 Jan 28:172957. doi: 10.1016/j.ejphar.2020.172957. [Epub ahead of print]
Page 19 Professional awards and recognition
• Brittany Abeln, RN: 2nd Place Poster Award, • Kwyn Morales, PharmD: Arizona Pharmacy Association International Society of Psychiatric-Mental Health Pharmacy Appreciation Award; The University of Nurse Annual Conference Arizona Quality Improvement Project Presentations First Place Award–Tucson • Rhys Axon, MPharm, MS, PhD: Bronze Medal Winning Poster Abstract, Academy of Managed Care Pharmacy; • Milap Nahata, MS, PharmD: American Pharmacists Gold Medal Winning Poster Abstract, Pharmacy Association Gloria Niemeyer Francke Leadership Quality Alliance Mentor Award
• Jenny Bingham, PharmD, BCACP: Pharmacy Times • Natasha Parker (Pharmacy Intern): American & Parata System’s Next-Generation™ Pharmacist- Pharmacists Association National Patient Counseling Technology Innovator of the Year Award National Competitor
• Malavika Deodhar: Winner, People’s Choice Award, • Kevin Reger, CPhT: Arizona Pharmacy Association Past 3-minute thesis, St. Albert’s Research Day, Creighton Technician at Large Award University • Belle Soyfer (Pharmacy Intern): Clarion • Jessica DiLeo, PharmD, BCGP, BCACP: Arizona Interprofessional Case Competition Fourth Place Pharmacy Association Past President Award Winner
• Kristin Calabro, PharmD: The University of Arizona • Ann M. Taylor, MPH, MCHES: Bronze Medal Winning Quality Improvement Project Presentations First Poster Abstract, Journal of Managed Care & Specialty Place–Phoenix Pharmacy Conference
• Whitney Everett, PharmD: The University of Arizona • Victoria Towers, RN: 4th Annual El Rio/The Wright Quality Improvement Project Presentations First Place Center Virtual Health Research Fair Community Award–Tucson Impact Award
• Sandra Leal, PharmD, MPH, FAPhA, CDE: American • Shannon Vaffis, MPH, PMP: International Society for Pharmacists Association President-Elect Pharmacoeconomics and Outcomes Research (ISPOR) Distinguished Service Award at the ISPOR Annual • Robert Lipsy, PharmD, BCACP, FAzPA: Arizona Meeting President’s Dinner; Travel Award, ISPOR Pharmacy Association Pharmacy Appreciation Award • Terri Warholak, PhD, RPh, CPHQ, FAPhA: • Breanne Lott, MPH, CPH: Health Research Award, The University of Arizona Award for Excellence, Coverdell Fellows Outreach Showcase, The University Department of Pharmacy Practice and Science; Bronze of Arizona; Jack Vaughn Leadership Award, Coverdell Medal Winning Poster Abstract, Journal of Managed Fellows Program, The University of Arizona; Best Care & Specialty Pharmacy Conference; Gold Medal Student Poster, International Cancer Education Winning Poster Abstract, The Pharmacy Quality Conference Alliance Annual Meeting
• Srujitha Marupuru, PharmD: Katheryne B. Willock Library Research Award, The University of Arizona Student Showcase; Best Human Health Research Award, The University of Arizona Student Showcase
• Lorraine Mobley: Alachua County Association of Pharmacists Pharmacist of the Year Award; Alumni Inductee, Phi Lambda Sigma Pharmacy Leadership Association
Page 20 Professional awards and recognition Professional leadership roles
• Rhys Axon, PhD, MPharm, MS: Member, Research • Dani Schiefer, PharmD: Member, Pharmacy Quality Affairs Committee Alliance Measure Development Panel
• Kevin Barton, PharmD: Vice Chair of Communications, • Nicole Scovis, PharmD, BCPS, BCACP: Past-Chair, Arkansas Pharmacists Association; Member, American Arizona Pharmacy Association Mentor Connection Pharmacists Association Fellow Awards Committee Program Special Interest Groups Steering Committee; Past-Chair, Arizona Pharmacy Association (AzPA) • Jenny Bingham, PharmD, BCACP: Past Chair, Continuing Education Committee; Member, AzPA American Pharmacists Association Telehealth Special Board of Pharmacy Specialties & Clinical Committees; Interest Group; Member Spokesperson, American Member, American Pharmacists Association Medication Pharmacists Association; Abstract Reviewer, Management Clinical, Business Model, and Chronic American Pharmacists Association APhA2020 Care Management Committees; Member, American Contributed Papers Program; Member, Arizona Health College of Clinical Pharmacy Ambulatory Care Practice Improvement Plan Initiative for Heart Disease & Stroke and Research Network; Contributor, iForumRx Workgroup; Member, Arizona Pharmacy Association (AzPA) Mentor Connection Program Special Interest • Mindy Smith, BSPharm, RPh, MHA: Chair, National Group Steering Committee; Member, AzPA Board of Council for Prescription Drug Programs, Foundation Pharmacy Specialties Committee; President, TRHC and Secretary of the Alliance for Integrated Medication Research Strategy Committee Management
• Jonathan Bosold, PharmD: Member, Pharmacy Quality • Ann M. Taylor, MPH, MCHES: Member, Academy Alliance Measure Validity Panel of Managed Care Pharmacy; American Public Health Association, Public Health Education/Health Promotion • Kristin Calabro, PharmD: Chair, American Pharmacists & Pharmacy Sections Association Telehealth Special Interest Group • Jacques Turgeon: Treasurer, American Society for • Jessica DiLeo, PharmD, BCACP, BCGP: Past Clinical Pharmacology President, Arizona Pharmacy Association • Shannon Vaffis, MPH, PMP: President, The • Patrick Hryshko, PharmD: Secretary, Arizona University of Arizona International Society for Pharmacy Association Pharmacoeconomics and Outcomes Research (ISPOR) Student Chapter; Chair, Survey and Evaluation • Sandra Leal, PharmD, MPH, FAPhA, CDE: Second Committee, ISPOR; Member, Global Student Council Vice-Chair, El Rio Health Center Board and Network, ISPOR
• Breanne Lott, PhD, MPH, CPH: Health Behavior • Terri Warholak, PhD, RPh, CPHQ, FAPhA: Inaugural Health Promotion Representative, Mel & Enid Member, Content Development Advisory Committee, Zuckerman College of Public Health Student Affairs Pharmacy Quality Alliance (PQA); Delegate, American Committee; Member, Public Health Research & Poster Pharmacists Association (APhA) Annual Meeting Forum Planning Committee; President, Alpha Nu House of Delegates; Chair Elect, Economic and Social (Arizona) Chapter of Delta Omega National Public Sciences (ESAS) Section, APhA; Member, Education Health Honorary Society Standing Committee, APhA; Reviewer, Annual Meeting Abstracts, Academy of Pharmacy Practice • Srujitha Marupuru, PharmD: Track Representative, Management and ESAS Sections; Member, Medication Graduate Student Council, Health Policy and Outcome Safety Curriculum Workgroup, International Society Department; President-Elect, The University of Arizona for Quality in Health Care; Member, National Quality International Society for Pharmacoeconomics and Forum Scientific Methods Panel, National Quality Outcomes Research Student Chapter Forum
• Jared Safran, PharmD, MS: Board Member, Academy of Managed Care & Specialty Pharmacy Finance Committee
Page 21 Peer reviewers for journals
• Elizabeth Anderson, MPH: BMC Women’s Health; Journal of Interprofessional Care; Breast Cancer Research and Treatment
• Rhys Axon, PhD, MS: Currents in Pharmacy Teaching and Learning; Journal of Clinical Medicine
• Jenny Bingham, PharmD, BCACP: Pharmacy; Journal of the American Pharmacists Association; Arizona Journal of Pharmacy; Journal of Telemedicine and Telecare; Mental Health Clinician
• Breanne Lott, MPH, CPH: Journal of Cancer Education; University of Michigan Pre-Publication Support Services
• Ann M. Taylor, MPH, MCHES: Pharmacy Practice; International Journal of Pharmacy Practice; Journal of Managed Care & Specialty Pharmacy
• Terri Warholak, PhD, RPh, CPHQ, FAPhA: peer reviewer for numerous professional journals
2019 - 2020 University of Arizona Residents: Dr. Stanislaw pictured middle row, 3rd from left; Dr. De Santiago pictured bottom row, 1st from left
Page 22 Peer reviewers for journals Postgraduate residency programs
Postgraduate Year-2 Ambulatory Care Pharmacy Residency Program Site name: The University of Arizona College of Pharmacy/ SinfoníaRx Medication Management
Dr. Jenny Bingham is Director of Ambulatory Care Residency Programs & Research at TRHC and a Clinical Instructor in the Department of Pharmacy Practice and Science at The University of Arizona. She is a board-certified Ambulatory Care Pharmacist. Dr. Bingham is also certified in Psychiatric Pharmacy. Her passion is advancing the role of pharmacists in the telehealth setting, as demonstrated by her role as Chair of the American Pharmacists Association's Telehealth Special Interest Group, where she led her team to create one of the first advanced professional training series for telehealth pharmacists. She specializes in research related to innovative pharmacist roles in chronic care management, transitions of care, epilepsy, and neuropsychiatric pharmacy settings.
Dr. Annette De Santiago is a postgraduate year-2 Ambulatory Care Pharmacy Resident with The University of Arizona College of Pharmacy/SinfoníaRx Medication Management Program. She received a Doctor of Pharmacy degree from Southwestern Oklahoma State University College of Pharmacy in Weatherford, Oklahoma. She completed a postgraduate year 1 pharmacy practice residency in South Texas at Doctors Hospital at Renaissance in affiliation with Texas A&M University Irma Lerma Rangel College of Pharmacy. Dr. De Santiago is currently working on a research project related to the integration of a concierge pharmacist into a community-based clinic interprofessional healthcare team model.
Dr. Jennifer Stanislaw is a postgraduate year-2 Ambulatory Care Pharmacy Resident with The University of Arizona College of Pharmacy/SinfoníaRx Medication Management Program. She received a Doctor of Pharmacy degree at Pacific University School of Pharmacy near Portland, Oregon. Following graduation, she worked with Pacific University as an Academic and Ambulatory Care Fellow before relocating to Tucson to further her experience in Ambulatory Care. Her primary interests include chronic disease management and academia. Dr. Stanislaw is currently working on a research project related to the impact of a pharmacist-delivered comprehensive medication review on chronic disease health markers.
Page 23 Postgraduate residency programs
Postgraduate Year-1 Pharmacy Practice Residency Program Site name: Tabula Rasa HealthCare
Dr. Nishita Shah Amin is Director of Pharmacy Practice Residency Programs for the TRHC Applied Precision Pharmacotherapy Institute (APPI) at the TRHC Moorestown, New Jersey, campus. Dr. Amin is responsible for mentoring pharmacists to utilize their accumulated knowledge and experiences in order to practice personalized and precision medicine and to excel in their future professional endeavors. In addition, she collaborates with key stakeholders in order to mentor and foster residency-related research projects and company initiatives. Dr. Amin is also actively working to accredit a postgraduate year 2 Pharmacogenomics Program.
Dr. Anna Furman received a Doctor of Pharmacy degree from the Ohio Northern University Raabe College of Pharmacy in 2019. She is currently completing a postgraduate year 1 pharmacy practice residency at TRHC, with a focus on geriatric personalized medicine and targeted therapeutics. Dr. Furman is currently working on an implementation research project related to antipsychotic deprescribing in a Program of All-Inclusive Care for the Elderly (PACE) facility.
Page 24 Dr. Shabnam Shojaat received a Doctor of Pharmacy degree from the University of Maryland School of Pharmacy in 2019. She is currently completing a postgraduate year 1 pharmacy practice residency at TRHC, with a focus on geriatric personalized medicine and targeted therapeutics. Dr. Shojaat is currently working on a research project focused on a pharmacist-led pharmacogenomics clinical service within the Program of All-Inclusive Care for the Elderly (PACE) with a focus on opioids.
Dr. Stacy-Ann Wright received a Doctor of Pharmacy degree from the St. John Fisher College Wegmans School of Pharmacy in Rochester, New York, in 2019. She is currently completing a postgraduate year 1 pharmacy practice residency at TRHC, with a focus on geriatric personalized medicine and targeted therapeutics. Dr. Wright is currently working on a research project focused on a critical appraisal of drug interaction databases.
Page 25 Current research projects
1. Hesperos, Inc.: Torsadogenic Risk Evaluation of 7. Assessing the Root Causes of Medication Non- Physiological and Supraphysiological Dosing Adherence Researchers: Jacques Turgeon, Veronique Michaud, A retrospective study evaluating the reasons for James Hickman intentional non-adherence to medication regimens. Researchers: Jenny Bingham, Kevin Barton, The 2. University of Florida Center for Pharmacometrics & University of Arizona College of Pharmacy Quality Systems Pharmacology Improvement Student Group Pharmacometrics Modeling and Simulation of the Probe Drug Tramadol Administered Alone or While 8. Residency Research Collaboration Across Multiple Subjected to Competitive Enzyme Inhibition Institutions Researchers: Jacques Turgeon, Veronique Michaud, A descriptive study evaluating unique learning Stephan Schmidt, Tao Long experiences and protocols associated with the postgraduate and fellowship residency programs. 3. University of Florida Center for Pharmacometrics & Researchers: Nicki Scovis, Ann Taylor, Rhys Axon, Terri Systems Pharmacology Warholak PBPK Modeling of Clopidogrel and Its Active Metabolite When Administered Alone or During 9. Mobile Health, eHealth, and Electronic Interventions Concomitant Administration With Esomeprazole to Improve Medication Adherence in DM, CHOL, and Considering Time-Dependent Inhibition HTN: A Systematic Review Researchers: Jacques Turgeon, Veronique Michaud, A systematic review assessing differences in proportion Karthik Lingineni of days covered and medication possession ratio rates in patients with chronic conditions. 4. DARTNet Institute Researchers: Jenny Bingham, Armando Silva An Observational Exploration of Various Medication Almodovar, Ann Taylor, Yawen Li, Natalie Toselli, Risk Scores Calculated Using Electronic Health Record Shawna Fox, Melissa Black Data in a General Population and Correlated to Medical Outcomes 10. Improving Comprehensive Medication Review Researchers: Jacques Turgeon, Veronique Michaud, Completion Rates Using a Revised Call Script Heather Anderson A prospective study evaluating the effectiveness of a new call script to engage patients and increase 5. Four Seasons: Hospice, Palliative Care comprehensive medication review completion rates. A Prospective Multicenter Cohort Study to Evaluate Researchers: Avital Gurman, Carolyn Brown, Saul the Characteristics and Clinical Implications of a Clinical Ortega Decision Support System and of Pharmacogenomic Information Relevant to Polypharmacy Actions in 11. Patient Outcomes Beyond Comprehensive Patients With Advanced Illness Who Are Receiving Medication Review Interventions Multiple Drugs for Pain and Other Disorders A retrospective study evaluating the impact Researchers: Jacques Turgeon, Veronique Michaud, of pharmacist-delivered interventions and Janet Bull recommendations during a comprehensive medication review on health markers and chronic condition 6. Comprehensive Medication Review Completion in management. Medically Underserved Areas and Populations Researchers: Jennifer Stanislaw, Jenny Bingham, Nicki A retrospective study to evaluate the completion rate Scovis of comprehensive medication reviews in both rural and non-rural medically underserved areas and population. Researchers: Jenny Bingham, Lisa Le, Isabel Paulk
Page 26 Current research projects
12. Assessing perception of a concierge pharmacist service in a provider office setting A prospective survey study evaluating the perception of an interprofessional team working with a concierge pharmacist. Researchers: Annette De Santiago, Jenny Bingham, Kevin Boesen
13. Rotation Student Management Cost Analysis A retrospective study evaluating cost effectiveness of implementing a position dedicated to advanced pharmacy practice experience administration. Researchers: Cameron Haun, The University of Arizona College of Pharmacy Quality Improvement Student Group
14. Board of Pharmacy Specialties Certification Effect on Job Satisfaction A prospective survey study analyzing the impact of Board of Pharmacy Specialties certification on employee job satisfaction. Researchers: Nicholas Ong, The University of Arizona College of Pharmacy Quality Improvement Student Group
15. Assessing Adherence Improvement & Gaps in Care Medications in RxCompanion A descriptive study determining if drugs listed as contraindicated to drugs that would be recommended by call centers based on Add / Adherence Alerts are in- fact contraindicated according to the medical literature. Researchers: Bob Lipsy, Whitney Everett, The University of Arizona College of Pharmacy Quality Improvement Student Group
16. Assessing Rate of Medication Errors and Drug-Drug Interactions Identified in a Retail Community Setting A descriptive study evaluating for trends between pharmacist shift time and medication error incidence. Researchers: Jenny Bingham, Max Jacobson, Nestor Lopez, Yuchen Xu, Christopher Zermeno, Andrew Escobedo
17. Effectiveness of a Clinical Decision Support System in Identifying Drug-Drug Interactions in a Medication Therapy Management Setting A prospective study evaluating for improved clinical decision making through use of a support system. Researchers: Jenny Bingham, Ann Taylor, Rhys Axon, Jacques Turgeon, Veronique Michaud
Page 27 1-866-648-2767 [email protected] trhc.com